| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/07/2011 | WO2011039196A1 Improvements to pressurised metered dose inhalers |
| 04/07/2011 | WO2011039144A1 Substances containing disulfide groups for self-assembly carriers for controlled release of an active ingredient |
| 04/07/2011 | WO2011038872A1 Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate |
| 04/07/2011 | WO2011038754A1 Oral care compositions containing human recombinant interleukin-1 |
| 04/07/2011 | WO2011038701A1 Hepatitis b virus antigen formulation for cell stimulation followed by therapeutic immunization |
| 04/07/2011 | WO2011038683A1 Controlled release formulation of carvedilol |
| 04/07/2011 | WO2011038574A1 Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders |
| 04/07/2011 | WO2011038485A1 Crosslinked hydrogels and related method of preparation |
| 04/07/2011 | WO2011038446A1 Cosmetic foam |
| 04/07/2011 | WO2011018801A3 Solid oral dosage form of ziprasidone |
| 04/07/2011 | WO2011018583A3 Novel pharmaceutical formulations against drug misuse |
| 04/07/2011 | WO2011014766A3 Crystallization method and bioavailability |
| 04/07/2011 | WO2010139752A3 Stabilised composition comprising at least one adrenergic compound |
| 04/07/2011 | WO2010139751A3 Stabilised composition comprising at least one adrenergic compound |
| 04/07/2011 | WO2010130728A3 Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers |
| 04/07/2011 | WO2010127254A3 Thermoresponsive, biodegradable, elastomeric material and uses therefor |
| 04/07/2011 | WO2010116382A3 Stable pharmaceutical compositions of diclofenac |
| 04/07/2011 | WO2010108108A3 Polyamine derivatives |
| 04/07/2011 | WO2010103544A3 A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants |
| 04/07/2011 | WO2010088527A3 Peptides and nanoparticles for therapeutic and diagnostic applications |
| 04/07/2011 | WO2010043630A3 A delivery system for rna |
| 04/07/2011 | WO2010041255A3 Liposomal systems comprising sphingomyelin |
| 04/07/2011 | WO2010038091A9 Compositions comrrising amlodipine and bisoprolol |
| 04/07/2011 | WO2010022276A9 Methods of processing multi-phasic dispersions |
| 04/07/2011 | WO2010006143A3 Transdermal estrogen device and delivery |
| 04/07/2011 | WO2009133408A3 Protein formulation |
| 04/07/2011 | US20110082482 Materials and Methods for Nerve Repair |
| 04/07/2011 | US20110082448 Pharmaceutical Compositions |
| 04/07/2011 | US20110082427 Bioresorbable embolization microspheres |
| 04/07/2011 | US20110082199 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues |
| 04/07/2011 | US20110082076 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 04/07/2011 | US20110082040 Composition and method for delivery of substances in a dry mode |
| 04/07/2011 | US20110081422 Prolonged release of local anesthetics using microparticles and surgery applications |
| 04/07/2011 | US20110081421 Methods of regulating renalase (monoamine oxidase c) |
| 04/07/2011 | US20110081420 Method of forming prolonged-release injectable steroids |
| 04/07/2011 | US20110081419 Ion exchange resin treated to control swelling |
| 04/07/2011 | US20110081418 Transdermal absorption enhancer |
| 04/07/2011 | US20110081417 Surgical compositions |
| 04/07/2011 | US20110081416 Ordered mesoporous silica material |
| 04/07/2011 | US20110081415 Coating apparatus |
| 04/07/2011 | US20110081414 Method for Encapsulation of Orally Ingested Materials to Alter the Site of Digestion, Site of Action, or Stability |
| 04/07/2011 | US20110081413 Pharmaceutical Compositions Comprising Phosphate-Binding Polymer |
| 04/07/2011 | US20110081412 Orally disintegrable tablets |
| 04/07/2011 | US20110081411 Orally Administered Corticosteroid Compositions |
| 04/07/2011 | US20110081410 Therapeutic agent for local inflammation |
| 04/07/2011 | US20110081409 Selective inhibitors of histone deacetylase |
| 04/07/2011 | US20110081408 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/07/2011 | US20110081407 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/07/2011 | US20110081406 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/07/2011 | US20110081405 Zeolite Formulation And Use Thereof For The Prevention And Therapy Of Diseases Caused By Infections With Herpes Simplex Virus Type 1 And Type 2 |
| 04/07/2011 | US20110081404 Novel liposome compositions |
| 04/07/2011 | US20110081403 Histone octamers for increased nucleic acid transfer |
| 04/07/2011 | US20110081402 Cosmetic base comprising collagen-modified liposome and skin cosmetic containing the same |
| 04/07/2011 | US20110081401 Dermal patch comprising chondrus crispus extract |
| 04/07/2011 | US20110081400 Nutritional composition for bariatric surgery patients |
| 04/07/2011 | US20110081398 Multi-mechanism surgical compositions |
| 04/07/2011 | US20110081394 Methods of attaching a molecule-of-interest to a microtube |
| 04/07/2011 | US20110081393 Cooling sensation agent composition, sensory stimulation agent composition and use of the same |
| 04/07/2011 | US20110081389 Composition comprising a mixture of active principles, and method of preparation |
| 04/07/2011 | US20110081387 Liposomes encapsulating an oxazolidin-2-one compound |
| 04/07/2011 | US20110081386 Controlled release of active agents from oleosomes |
| 04/07/2011 | US20110081385 Compositions and Methods for Sleep Regulation |
| 04/07/2011 | US20110081384 Methods of wound care and treatment |
| 04/07/2011 | US20110081377 Aerosolized genetic vaccines and methods of use |
| 04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |
| 04/07/2011 | US20110081302 Process for the obtention of purified heptafluoropropane |
| 04/07/2011 | US20110081301 Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate |
| 04/07/2011 | US20110081293 Methods and compositions related to clot-binding lipid compounds |
| 04/07/2011 | DE20321836U1 Hydroxyalkylstärkederivate Hydroxyalkylstärkederivate |
| 04/07/2011 | DE102010035701A1 Schneidvorrichtung für TDS und ODF Cutter for TDS and ODF |
| 04/07/2011 | DE10141652B4 Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung The transdermal therapeutic system based on polyacrylate pressure-sensitive adhesives having no functional groups and its use |
| 04/07/2011 | CA2776474A1 Topical tetracycline compositions |
| 04/07/2011 | CA2776472A1 Microparticle compositions and methods for treating age-related macular degeneration |
| 04/07/2011 | CA2776366A1 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| 04/07/2011 | CA2776288A1 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 04/07/2011 | CA2776266A1 Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate |
| 04/07/2011 | CA2776217A1 Cosmetic foam |
| 04/07/2011 | CA2776195A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | CA2776173A1 Cofactors and methods of use for individuals |
| 04/07/2011 | CA2776160A1 Smoking cessation with body weight maintenance and nutritional supplement |
| 04/07/2011 | CA2776141A1 Reduced-odor polyol composition and method of producing same |
| 04/07/2011 | CA2775905A1 An intrauterine system |
| 04/07/2011 | CA2775890A1 Methods and compositions for deterring abuse |
| 04/07/2011 | CA2775833A1 Mucoadhesive polymers having vitamin b partialstructures |
| 04/07/2011 | CA2775794A1 Formulation of hepatitis b virus antigens for cellular stimulation followed by therapeutic immunization |
| 04/07/2011 | CA2775670A1 Crosslinked hydrogels and related method of preparation |
| 04/07/2011 | CA2775317A1 Topical formulation for diabetic foot ulcers |
| 04/07/2011 | CA2775061A1 Methods and compositions for treatment of raynaud's phenomenon |
| 04/07/2011 | CA2773483A1 Olopatadine compositions and uses thereof |
| 04/07/2011 | CA2772127A1 Formulations for c-met kinase inhibitors |
| 04/07/2011 | CA2768968A1 Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same |
| 04/06/2011 | EP2305822A2 Methods and compositions for diseases associated with Amyloidosis |
| 04/06/2011 | EP2305722A1 Water-soluble acrylic acid salt polymer and gelling base |
| 04/06/2011 | EP2305694A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 04/06/2011 | EP2305683A1 Pharmaceutical dosage form comprising oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone |
| 04/06/2011 | EP2305639A2 Organic compounds |
| 04/06/2011 | EP2305373A1 Microcapsule, process for production thereof, and food or beverage containing microcapsule |
| 04/06/2011 | EP2305308A1 Remedies for diseases to be applied to eye |
| 04/06/2011 | EP2305307A1 Analgesic anti-inflammatory preparation for external application |
| 04/06/2011 | EP2305292A1 S/o type transdermal immunizing agent |